Lantheus Medical Imaging, Inc. to Present Data on Cardiovascular PET Imaging Pipeline Candidates at SNM Annual Meeting Read more about Lantheus Medical Imaging, Inc. to Present Data on Cardiovascular PET Imaging Pipeline Candidates at SNM Annual Meeting
Lantheus Medical Imaging, Inc. Announces Appointment of Dana S. Washburn, M.D., as Vice President, Clinical Development and Medical Affairs Read more about Lantheus Medical Imaging, Inc. Announces Appointment of Dana S. Washburn, M.D., as Vice President, Clinical Development and Medical Affairs
Lantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158), a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session Read more about Lantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158), a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session
Lantheus Medical Imaging, Inc. to Present New Data on Novel PET Cardiac and Heart Failure Imaging Agents at the American College of Cardiology 59th Annual Scientific Session in Atlanta Read more about Lantheus Medical Imaging, Inc. to Present New Data on Novel PET Cardiac and Heart Failure Imaging Agents at the American College of Cardiology 59th Annual Scientific Session in Atlanta
Lantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as Read more about Lantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as
Lantheus Medical Imaging, Inc. Launches ABLAVAR™ (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent Read more about Lantheus Medical Imaging, Inc. Launches ABLAVAR™ (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent
Data Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in the U.S. Presented at MRA-Club 09: 21st Annual International Conference on Magnetic Resonance Angiography Read more about Data Featuring Gadofosveset Trisodium, the First and Only MRA Blood Pool Agent Approved in the U.S. Presented at MRA-Club 09: 21st Annual International Conference on Magnetic Resonance Angiography
Lantheus Medical Imaging, Inc. Initiates Phase 1 Study Evaluating Safety and Dosimetry of Novel Heart Failure Imaging Agent Read more about Lantheus Medical Imaging, Inc. Initiates Phase 1 Study Evaluating Safety and Dosimetry of Novel Heart Failure Imaging Agent
Lantheus Continues to Address Industry Shortage of Mo-99 Resulting from Prolonged NRU Reactor Shutdown Read more about Lantheus Continues to Address Industry Shortage of Mo-99 Resulting from Prolonged NRU Reactor Shutdown
Lantheus Medical Imaging, Inc. Announces FDA and Health Canada Approval of Australian Nuclear Science and Technology Organisation (ANSTO)-Supplied Key Medical Isotope to Manufacture Technelite® Generator Read more about Lantheus Medical Imaging, Inc. Announces FDA and Health Canada Approval of Australian Nuclear Science and Technology Organisation (ANSTO)-Supplied Key Medical Isotope to Manufacture Technelite® Generator
